IRINOTECAN ACT irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

irinotecan act irinotecan hydrochloride trihydrate 40 mg/2 ml concentrated injection vial

medis pharma pty ltd - irinotecan hydrochloride trihydrate, quantity: 40 mg - injection, concentrated - excipient ingredients: (s)-lactic acid; water for injections; sodium hydroxide; sorbitol - for use as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum and in patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

irinotecan accord irinotecan hydrochloride trihydrate 100 mg/5 ml concentrated injection vial

accord healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 100 mg - injection, concentrated - excipient ingredients: hydrochloric acid; lactic acid; sodium hydroxide; water for injections; sorbitol - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

irinotecan accord irinotecan hydrochloride trihydrate 40 mg/2 ml concentrated injection vial

accord healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 40 mg - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sorbitol; lactic acid - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Lipitor 10mg tablets Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

lipitor 10mg tablets

de pharmaceuticals - atorvastatin calcium trihydrate - oral tablet - 10mg

Lipitor 10mg tablets Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

lipitor 10mg tablets

de pharmaceuticals - atorvastatin calcium trihydrate - oral tablet - 10mg